Beiersdorf stock weighs NIVEA pressure against Derma growth
Published on 11/06/2026 at 18:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSMixed signals shape Beiersdorf outlook
- NIVEA remains under pressure while Derma, La Prairie and Health Care support the portfolio.
- Management maintained its 2026 sales and margin guidance despite the mixed brand performance.
- HSBC turned more cautious, highlighting slower NIVEA shopper sales and limited margin upside.
Beiersdorf's third-quarter update from October 27 showed a split performance across its consumer brands. According to the Beiersdorf third-quarter results, group sales declined 1.3 percent organically to 2.362 billion euros. Derma grew 10.6 percent organically, while NIVEA fell 4.9 percent.
What has changed since our last report
The latest update adds that a commercial dispute in Russia accounted for 170 basis points of NIVEA's quarterly decline and has been resolved, with normal sales expected to resume in the fourth quarter. Tesa sales fell 4.3 percent organically as semiconductor shortages weighed on its Electronics business.
Beiersdorf kept its 2026 guidance unchanged. The group still expects a low-single-digit organic sales decline and an EBIT margin excluding special factors of at least 11.8 percent. The Consumer Business Segment is expected to post a margin of at least 11.0 percent.
HSBC downgraded Beiersdorf to Hold from Buy and cut its price target from 90 euros to 88 euros, according to the latest market report. The bank cited slower NIVEA shopper sales and limited scope for margin improvement, keeping execution of the turnaround central for investors.
The real-time quote of Beiersdorf stock was 85.19 euros on Lang & Schwarz at 17:49 CET on Friday, November 6, 2026, 0.39 percent below the Xetra close of 85.52 euros on Friday, November 6.
Beiersdorf AG stock facts
- Company: Beiersdorf AG
- ISIN: DE0005200000
- Ticker: BEI.DE
- Market: Xetra
- Lang & Schwarz quote: 85.19 euros at 17:49 CET on November 6, 2026
- Change versus Xetra close: 0.39 percent below 85.52 euros on November 6, 2026
- 2026 group guidance: Low-single-digit organic sales decline and EBIT margin excluding special factors of at least 11.8 percent
The DAX provides the broader market setting for German consumer stocks.
More news and analyses on Beiersdorf stock track the NIVEA turnaround, portfolio growth and margin risks.
